Semaglutide vs AOD-9604

Semaglutide wins for delivering dramatic, evidence-backed bodyweight and fat loss via GLP-1 agonism, especially for users needing maximal appetite suppression or fighting true obesity. It makes adherence to aggressive calorie deficits feel effortless at both clinical and microdose protocols, with side-effect management being the main skill requirement.

AOD-9604 wins for targeted, side-effect-free lipolysis—especially as a mild helper to nudge stubborn fat on a real deficit or to bias fat loss over lean tissue loss (as an adjunct to GLP-1s, AAS, or GH runs). It's extremely well-tolerated, non-hormonal, and useful when you want zero impact on muscle, glucose, or IGF-1.

Pick Semaglutide if:

• You need aggressive, sustained appetite suppression (diet adherence is your main battle).
• Chasing large-scale fat loss (10–20%+ bodyweight) or rapid recomposition.
• Want to eliminate "food noise" during a prep, blast clean-up, or lifestyle cut.
• You're running a high hunger drive from AAS, GH, or bulking protocols and want to clamp back control.
• Willing to manage GI side effects (nausea, constipation) and titrate dose to effect.

Pick AOD-9604 if:

• You want a side-effect-free, non-hormonal lipolytic support (not your primary driver).
• You're lean(ish) but fighting stubborn fat patches, especially around the midsection.
• Looking to safeguard muscle while in a deficit (AOD is catabolism-neutral, GLP-1s can cut lean mass without resistance training).
• Want to stack with a GLP-1 or GH secretagogue for targeted fat bias without extra suppression or sides.
• Women and men running similar protocols with minimal risk or bloodwork demand.